# Build an ASCO or AACR watchlist Canonical URL: https://biopharmsignal.com/use-cases/biotech-newsletter-writers/build-an-asco-or-aacr-watchlist Role: [Biotech Newsletter Writers](https://biopharmsignal.com/use-cases/biotech-newsletter-writers.md) Category: Conference and thematic coverage Last updated: 2026-07-26 Prioritize companies and programs before abstracts arrive. ## The Situation A biotech publication is preparing for a major oncology or research meeting with hundreds of companies and abstracts. ### Best Fit Independent writers, newsletter teams, financial media creators, podcasters, and editors covering biotechnology and pharmaceutical companies. ## The Challenge Prioritize companies and programs before abstracts arrive. The challenge is to preserve the source, define what changed, and connect the update to a decision instead of collecting disconnected information. ## How To Think About The Task A biotech publication is preparing for a major oncology or research meeting with hundreds of companies and abstracts. For newsletter writers, the useful response is not simply to collect more links. The task is to decide what the new information changes, which source supports it, who needs to respond, and when the question should be reviewed again. Prioritize companies and programs before abstracts arrive. The challenge is to preserve the source, define what changed, and connect the update to a decision instead of collecting disconnected information. A repeatable process keeps the work proportional to the decision and creates a record that another investor, analyst, editor, or team member can understand later. ### Start with the decision this work must support “Build an ASCO or AACR watchlist” becomes manageable when the user names the decision before opening more sources. The decision might be whether to escalate an event, update a thesis, change a calendar, commission deeper research, publish a story, or continue monitoring. A defined decision also makes it easier to exclude information that is interesting but not currently useful. ### Build a source-linked change record The core monitoring set for this workflow includes audience-relevant programs, expected new versus encore data, abstract and session timing, prior evidence, competitive landscape. Each material update should retain its source and previous known state. That makes timing changes, accumulating evidence, and repeated execution patterns visible instead of leaving the user with an isolated snapshot. ### Turn monitoring into an owned output A conference editorial watchlist with program priority, expected evidence, prior-data baseline, session details, and assigned coverage. The output should state what changed, what remains uncertain, who owns any follow-up, and which future event will resolve the question. The publication plans high-value coverage before the abstract rush and avoids chasing every company announcement. ## Illustrative Example ### Illustrative workflow: build an asco or aacr watchlist Begin with the specific company, program, portfolio exposure, audience, or competitive set in scope. Review the highest-confidence source first, compare the disclosure with the previous record, and then use secondary context only where it helps explain the change. Complete the workflow by producing the defined deliverable rather than ending with a collection of tabs. Assign any unresolved question to an owner and set the next review around the most relevant clinical, regulatory, financial, strategic, or editorial event. ### Questions To Answer Before Making A Decision - What has changed in audience-relevant programs, and why does it matter? - What has changed in expected new versus encore data, and why does it matter? - What has changed in abstract and session timing, and why does it matter? - What has changed in prior evidence, and why does it matter? - What has changed in competitive landscape, and why does it matter? ## A Repeatable Workflow 1. Define the specific decision or research question behind “build an asco or aacr watchlist.” 2. Set the monitored scope around audience-relevant programs and expected new versus encore data. 3. Collect source-linked updates for abstract and session timing and record what changed from the prior state. 4. Review prior evidence together with competitive landscape before drawing a conclusion. 5. Produce the required output, assign follow-up ownership, and set the next review point. ## Signals To Keep Visible - Audience-relevant programs - Expected new versus encore data - Abstract and session timing - Prior evidence - Competitive landscape ## Common Mistakes - Starting the monitoring process without a defined decision question - Recording the latest state without preserving its source or previous state - Ending with collected information but no owner, conclusion, or next review ## Deliverable A conference editorial watchlist with program priority, expected evidence, prior-data baseline, session details, and assigned coverage. ## Practical Outcome The publication plans high-value coverage before the abstract rush and avoids chasing every company announcement. ## Where BioPharmSignal Fits Use LiveFeed and company pages for source-linked monitoring, the PDUFA Calendar for upcoming FDA milestones, and watchlists or alerts to keep relevant tickers and keywords visible. The workflow still requires independent research and judgment. ## Frequently Asked Questions ### Who is this workflow for? It is designed for biotech newsletter writers and adjacent biotech research users who need a repeatable, source-linked way to complete this task. ### What should this workflow produce? A conference editorial watchlist with program priority, expected evidence, prior-data baseline, session details, and assigned coverage. ### What is the practical benefit? The publication plans high-value coverage before the abstract rush and avoids chasing every company announcement. ## Related Workflows - [How Biotech Writers Build a Daily News Briefing](https://biopharmsignal.com/use-cases/biotech-newsletter-writers/daily-biotech-newsletter-briefing.md) - [How Newsletter Writers Build a Weekly Biotech Catalyst Roundup](https://biopharmsignal.com/use-cases/biotech-newsletter-writers/weekly-biotech-catalyst-roundup.md) - [How Biotech Writers Organize Medical Conference Coverage](https://biopharmsignal.com/use-cases/biotech-newsletter-writers/medical-conference-coverage-workflow.md) Format note: This is an illustrative workflow guide, not a named customer testimonial or a claim of investment performance.